LONDON--(BUSINESS WIRE)--The majority of deals within the lung cancer industry are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors lung cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms.
New market research study "Lung Cancer Partnering 2007-2012" elaborated by CurrentPartnering offers insightful understanding and access to the lung cancer partnering deals and agreements entered into by the world leading healthcare companies. Top lung cancer deals by value are examined, trends in lung cancer partnering deals are analysed, and lists of deals by company A-Z, industry sector, stage of development, technology type are provided within the report.
Report Details:
Title: Lung Cancer Partnering 2007-2012
Published: February, 2012
Pages: 250
Price: US$ 1,695
Report Contents:
EXECUTIVE SUMMARY
CHAPTER 1 – INTRODUCTION
CHAPTER 2 – TRENDS IN LUNG CANCER PARTNERING
2.1. Introduction
2.2. Lung cancer partnering over the years
2.3. Bigpharma lung cancer dealmaking activity
2.4. Lung cancer partnering by deal type
2.5. Lung cancer partnering industry sector
2.6. Lung cancer partnering by stage of development
2.7. Lung cancer partnering by technology type
2.8. Disclosed financial deal terms for lung cancer partnering
2.8.1 Lung cancer headline values
2.8.2 Lung cancer upfront payments
2.8.3 Lung cancer milestone payments
2.8.4 Lung cancer royalty rates
CHAPTER 3 – LEADING LUNG CANCER DEALS
3.1. Introduction
3.2. Top lung cancer deals by value
3.3. Top lung cancer deals involving bigpharma
CHAPTER 4 – DEALMAKING DIRECTORY
4.1. Introduction
4.2. Company A-Z
4.3. By deal type
Asset purchase
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Contract service
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Manufacturing
Marketing
Option
…
More new market research reports by CurrentPartnering can be found at http://marketpublishers.com/members/currentpartner/info.html